Minerva Neurosciences (NERV) Return on Equity [ROE] (2014 - 2022)
Minerva Neurosciences (NERV) posted Return on Equity [ROE] of -1266.04% for Q1 2022, down 1279.60 percentage points from 13.56% a year earlier and down 1014.47 percentage points from the prior quarter.
Powered by 
Analysis
Minerva Neurosciences (NERV) Return on Equity [ROE] (2014 - 2022) Analysis & Trends
For FY2021, Minerva Neurosciences' Return on Equity [ROE] came in at -164.60%, down 169.43 percentage points from FY2020.
- Annual Return on Equity [ROE] shows a five-year change of -126.11 percentage points (FY2016 to FY2021).
- In prior years, Minerva Neurosciences' Return on Equity [ROE] was 4.83% in FY2020 (+127.12 pp), -122.30% in FY2019 (-77.07 pp), -45.23% in FY2018 (-18.71 pp) and -26.52% in FY2017 (+11.98 pp).
- The Q1 2022 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q3 2014.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last four quarters, with an average year-over-year change of -130.67 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2021, with a gain of 318.40 percentage points; the weakest was Q1 2022, with a drop of 1279.60 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -251.57% (Q4 2021), -97.35% (Q3 2021) and -78.11% (Q2 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Minerva Neurosciences | 124.09 Mn | -188.49 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | -1,266.04% |
| Dec 31, 2021 | -251.57% |
| Sep 30, 2021 | -97.35% |
| Jun 30, 2021 | -78.11% |
| Mar 31, 2021 | 13.56% |
| Dec 31, 2020 | 3.63% |
| Sep 30, 2020 | -39.76% |
| Jun 30, 2020 | -76.03% |
| Mar 31, 2020 | -304.85% |
| Dec 31, 2019 | -178.64% |
| Sep 30, 2019 | -90.31% |
| Jun 30, 2019 | -73.94% |
| Mar 31, 2019 | -63.87% |
| Dec 31, 2018 | -52.23% |
| Sep 30, 2018 | -43.34% |
| Jun 30, 2018 | -38.86% |
| Mar 31, 2018 | -33.32% |
| Dec 31, 2017 | -30.73% |
| Sep 30, 2017 | -35.32% |
| Jun 30, 2017 | -36.56% |
API Access
Minerva Neurosciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NERV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();